Cognetivity To Deploy Cognitive Assessment Tool Across Largest Healthcare Network In UAE

Cognetivity Neurosciences (CSE: CGN) continued to take the Middle East by storm this morning. The firm has continued its pattern of signing with health care providers in the region, this time signing with the largest healthcare network in the United Arab Emirates.

The company has entered into an agreement with Abu Dhabi Health Services Company, an independent company that owns and operates all of the public hospitals and clinics across Abu Dhabi. The agreement will see Cognetivity’s CognICA cognitive assessment tool utilized under a pilot program, whereby it will be used as a screening tool across the network for cognitive impairment and brain health.

The healthcare network currently boasts 13 hospitals within its network, along with 36 primary healthcare clinics and 24 supporting facilities. The agency conducts five million outpatient and 100,000 inpatient visits annually, while acting as a pioneer in terms of digitalization of its healthcare network.

“We’re hugely excited about this latest deployment of our CognICATM technology and thrilled to confirm another major deal in the Middle East. To tackle the enormous global problem of brain health, including dementia, we have to massively improve the detection of early-stage impairment on a large scale, making brain health testing as routine as blood pressure monitoring. CognICATM is the perfect tool in every way for this job and this latest implementation further demonstrates the value that our technology adds to progressive healthcare systems,” commented CEO Sina Habibi.

The launch of the pilot program is viewed as a “first step” for the rollout of the firms flagship product across the healthcare network. If the program is successful, its expected that a large scale rollout will occur, with the tech used for the timely diagnosis of mild cognitive impairment as well as dementia.

Cognetivity Neurosciences last traded at $0.34 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Cognetivity To Deploy Flagship Assessment Tool At Florida-Based Clinic

The rollout of Cognetivity Neurosciences’ (CSE: CGN) flagship product, the CognICA cognitive assessment tool, continues....

Wednesday, May 25, 2022, 07:53:15 AM

Cognetivity Enters Paid Pilot Program With Japanese Insurance Giant

Cognetivity Neurosciences (CSE: CGN) appears to be on a roll when it comes to establishing...

Thursday, July 21, 2022, 08:25:36 AM

Cognetivity Signs Commercial Agreement With Emirates Health Services Of UAE

Cognetivity Neurosciences (CSE: CGN) has entered the mainstream. The company this morning announced that it...

Tuesday, February 1, 2022, 08:48:42 AM

Cognetivity Looks To Raise $3.0 Million To Fund US Expansion

Cognetivity Neurosciences (CSE: CGN) is looking to close out the year with a capital raise....

Thursday, December 16, 2021, 07:32:30 AM

Cognetivity: Tech For Brain Health Screening – The Daily Dive

Joining us again on The Daily Dive is Dr. Thomas Sawyer, COO of Cognetivity Neurosciences...

Tuesday, June 21, 2022, 01:30:00 PM